Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Burges

Showing results (31-40 of 118) with videos related to

Pageof 12
Sort By:
Journal of Ovarian Research|August 16, 2019
Inhibitor of apoptosis proteins are potential targets for treatment of granulosa cell tumors - implications from studies in KGNKonstantin Bagnjuk, Verena Jasmin Kast, Astrid Tiefenbacher, et al.
Clinical Chemistry and Laboratory Medicine|March 26, 2009
Predictive value of CA 125 and CA 72-4 in ovarian borderline tumorsMiriam S Lenhard, Stefanie Nehring, Dorothea Nagel, et al.
Critical Care (London, England)|May 18, 2012
The intravascular volume effect of Ringer's lactate is below 20%: a prospective study in humansMatthias Jacob, Daniel Chappell, Klaus Hofmann-Kiefer, et al.
Anticancer Research|August 30, 2008
PET-CT in recurrent ovarian cancer: impact on treatment planningMiriam S Lenhard, Alexander Burges, Thorsten R C Johnson, et al.
Annals of Surgical Oncology|February 19, 2010
Influence of residual tumor on outcome in ovarian cancer patients with FIGO stage IV disease: an exploratory analysis of the AGO-OVAR (Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group)Pauline Wimberger, Michael Wehling, Nils Lehmann, et al.
Healthcare (Basel, Switzerland)|August 26, 2022
Therapeutic Outcome of MR-Guided High-Intensity Focused Ultrasound (MR-HIFU) in Solitary versus Multiple Uterine FibroidsBernd Erber, Vincent Schwarze, Frederik Strobl, et al.
Frontiers in Endocrinology|March 8, 2021
G Protein-Coupled Estrogen Receptor Correlates With Dkk2 Expression and Has Prognostic Impact in Ovarian Cancer PatientsPatricia Fraungruber, Till Kaltofen, Sabine Heublein, et al.
Biomolecules|May 28, 2022
Gal-2 Increases H3K4me<sup>3</sup> and H3K9ac in Trophoblasts and PreeclampsiaLaura Hahn, Sarah Meister, Mareike Mannewitz, et al.
Cancers|July 4, 2019
Extracapsular Lymph Node Involvement in Ovarian CarcinomaSabine Heublein, Heiko Schulz, Frederik Marmé, et al.
International Journal of Molecular Sciences|January 2, 2019
Interaction of ERα and NRF2 Impacts Survival in Ovarian Cancer PatientsBastian Czogalla, Maja Kahaly, Doris Mayr, et al.
Pageof 12

Showing results (31-40 of 118) with videos related to

Sort By:
Pageof 12
Journal of Ovarian Research|August 16, 2019
Inhibitor of apoptosis proteins are potential targets for treatment of granulosa cell tumors - implications from studies in KGNKonstantin Bagnjuk, Verena Jasmin Kast, Astrid Tiefenbacher, et al.
Clinical Chemistry and Laboratory Medicine|March 26, 2009
Predictive value of CA 125 and CA 72-4 in ovarian borderline tumorsMiriam S Lenhard, Stefanie Nehring, Dorothea Nagel, et al.
Critical Care (London, England)|May 18, 2012
The intravascular volume effect of Ringer's lactate is below 20%: a prospective study in humansMatthias Jacob, Daniel Chappell, Klaus Hofmann-Kiefer, et al.
Anticancer Research|August 30, 2008
PET-CT in recurrent ovarian cancer: impact on treatment planningMiriam S Lenhard, Alexander Burges, Thorsten R C Johnson, et al.
Annals of Surgical Oncology|February 19, 2010
Influence of residual tumor on outcome in ovarian cancer patients with FIGO stage IV disease: an exploratory analysis of the AGO-OVAR (Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group)Pauline Wimberger, Michael Wehling, Nils Lehmann, et al.
Healthcare (Basel, Switzerland)|August 26, 2022
Therapeutic Outcome of MR-Guided High-Intensity Focused Ultrasound (MR-HIFU) in Solitary versus Multiple Uterine FibroidsBernd Erber, Vincent Schwarze, Frederik Strobl, et al.
Frontiers in Endocrinology|March 8, 2021
G Protein-Coupled Estrogen Receptor Correlates With Dkk2 Expression and Has Prognostic Impact in Ovarian Cancer PatientsPatricia Fraungruber, Till Kaltofen, Sabine Heublein, et al.
Biomolecules|May 28, 2022
Gal-2 Increases H3K4me<sup>3</sup> and H3K9ac in Trophoblasts and PreeclampsiaLaura Hahn, Sarah Meister, Mareike Mannewitz, et al.
Cancers|July 4, 2019
Extracapsular Lymph Node Involvement in Ovarian CarcinomaSabine Heublein, Heiko Schulz, Frederik Marmé, et al.
International Journal of Molecular Sciences|January 2, 2019
Interaction of ERα and NRF2 Impacts Survival in Ovarian Cancer PatientsBastian Czogalla, Maja Kahaly, Doris Mayr, et al.
Pageof 12